Your session is about to expire
← Back to Search
Prosthetic Device
To Assess the Utility of the Point Partial in a Clinical Take-home Study of Partial Hand Amputees
N/A
Waitlist Available
Research Sponsored by Point Designs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ~day 60: with prosthesis, 60 days post-fitting
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if the Point Partial prosthetic device helps people with partial finger amputations function better and feel better in everyday life. It aims to show that using this device outside the lab can provide real-world benefits.
Eligible Conditions
- Hand Amputation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ ~day 60: with prosthesis, 60 days post-fitting
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~~day 60: with prosthesis, 60 days post-fitting
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Upper Extremity
Disability of the Arm, Shoulder and Hand (DASH)
EuroQol-5 Dimension (EQ-5D-5L)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ProsthesisExperimental Treatment1 Intervention
Outcome measurements will be performed after the subject has been fit with a prosthesis at 3 different points in time: immediately post-fitting, \~30 days post-fitting, and \~60 days post-fitting
Group II: No ProsthesisActive Control1 Intervention
Baseline outcome measurements will be performed without a prosthesis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Point Partial
2021
N/A
~20
Find a Location
Who is running the clinical trial?
Arm DynamicsUNKNOWN
1 Previous Clinical Trials
13 Total Patients Enrolled
Point DesignsLead Sponsor
6 Previous Clinical Trials
55 Total Patients Enrolled
University of Colorado, DenverOTHER
1,810 Previous Clinical Trials
2,920,089 Total Patients Enrolled